Vimarsana
Biggest News Aggregation in the World

Page 12 - Communications Email News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Communications Email. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Communications Email Today - Breaking & Trending Today

ONTOZRY™ (cenobamate) receives positive CHMP opinion for the adjunctive treatment of uncontrolled focal onset seizures in adults* - Vimarsana News

ONTOZRY™ (cenobamate) receives positive CHMP opinion for the adjunctive treatment of uncontrolled focal onset seizures in adults*

ONTOZRY™ (cenobamate) receives positive CHMP opinion for the adjunctive treatment of uncontrolled focal onset seizures in adults* January 29, 2021 12:20 ET | Source: Arvelle Therapeutics Arvelle Therapeutics Positive CHMP opinion is an important milestone for Arvelle Therapeutics and cenobamate When approved, cenobamate will provide new hope in helping adult patients with uncontrolled focal epilepsy move closer to the goal of seizure reduction and seizure freedom ZUG, Switzerland, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Arvelle Therapeutics, an emerging biopharmaceutica...